Heterogeneity and cellular hierarchy of lung cDC2
肺 cDC2 的异质性和细胞层次
基本信息
- 批准号:10665348
- 负责人:
- 金额:$ 23.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-06 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdoptedAdoptive TransferAffectAllergicAlveolar MacrophagesAnimal ModelAspergillusAttenuatedBioinformaticsBloodCX3CR1 geneCategoriesCell CountCharacteristicsCollaborationsDataDendritic CellsDevelopmentDiseaseExtrinsic asthmaGene ExpressionHeterogeneityHypersensitivityITGAX geneImmune responseImmunityInflammationKnowledgeLungLung diseasesLymphoid CellMalignant NeoplasmsMapsMediatingModelingMouse StrainsMusMycosesMyeloid CellsNatural ImmunityOperative Surgical ProceduresParabiosisParasitic infectionPlayPopulationPulmonary InflammationRNAReporterResearchRestRoleSpecificityStainsTechniquesTestingadaptive immunityairway inflammationcell typehigh dimensionalityinsightinterestmouse modelnovelsingle-cell RNA sequencingtooltranscriptomic profilingtranscriptomics
项目摘要
Abstract
Dendritic cells (DCs) play a fundamental role in bridging innate and adaptive immunity. Among DC subtypes,
conventional DC2 (cDC2) are pivotal in multiple diseases including allergy, fungal & parasite infection, and
cancer. However, studying cDC2 has been challenged by the small cell number and a lack of the subset-
specific animal model. To better understand the characteristics and roles of cDC2 subsets, we have utilized the
cutting-edge, RNA-based high-throughput transcriptomic profiling technique known as single cell RNA-
sequencing (scRNA-seq). This approach has enabled us to better understand lung cDC2 in terms of diversity
and cellular hierarchy.
Our preliminary data indicate that lung cDC2 can be categorized into 6 distinct subsets. Of interest, lung
CX3CR1hicDC2 subset are origin of rest of 5 subsets. In aim 1, we will test whether other lung cDC2 subsets
are derived from the CX3CR1hicDC2 subset. In aim 2, we will test whether a cDC-specific CX3CR1 depletable
stain (CX3CR1-DTRcDC) is responsible not only Th2 immunity but also Th17 immune responses.
Successful completion of this project will provide us with a better understanding of heterogeneity and cellular
dynamic lineage trajectory of lung cDC2. Moreover, our new mouse strain, cDC specific CX3CR1 depletable
strain (CX3CR1-DTRcDC), will be a great asset to study cDC2-mediated diseases.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gye Young Park其他文献
Gye Young Park的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gye Young Park', 18)}}的其他基金
Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation
CX3CR1巨噬细胞介导的嗜酸性过敏性肺部炎症消退机制
- 批准号:
10625350 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation
CX3CR1巨噬细胞介导的嗜酸性过敏性肺部炎症消退机制
- 批准号:
10210655 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation
CX3CR1巨噬细胞介导的嗜酸性过敏性肺部炎症消退机制
- 批准号:
10403559 - 财政年份:2021
- 资助金额:
$ 23.99万 - 项目类别:
CSF1 Receptor-Mediated Tumor Microenvironment in Lung Cancer
CSF1 受体介导的肺癌肿瘤微环境
- 批准号:
10553138 - 财政年份:2020
- 资助金额:
$ 23.99万 - 项目类别:
CSF1 Receptor-Mediated Tumor Microenvironment in Lung Cancer
CSF1 受体介导的肺癌肿瘤微环境
- 批准号:
10376736 - 财政年份:2020
- 资助金额:
$ 23.99万 - 项目类别:
CSF1 Receptor-Mediated Tumor Microenvironment in Lung Cancer
CSF1 受体介导的肺癌肿瘤微环境
- 批准号:
9888672 - 财政年份:2020
- 资助金额:
$ 23.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.99万 - 项目类别:
Research Grant














{{item.name}}会员




